News

The randomised, placebo-controlled, double-blind study was presented at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting and Clinical Congress in Boston. Daiichi Sankyo said that these

Health Canada has a 45-day screening for acceptance process of the Rresponse by their Regulatory Project Management group. The acceptance of the Response triggers a new, 150-day review

Novartis Pharma claimed that following EC’s decision, the pediatric indication needs to be implemented through EU National Competent Authorities before Diovan will be available for pediatric use across

Bydureon is an investigational, extended-release medication for type 2 diabetes designed to deliver continuous therapeutic levels of exenatide in a single weekly dose. In accordance with its guidelines,

Tryton Medical said that more than 1,000 patients in Europe have been treated with the Tryton Side Branch Stent System, with more than 500 part of a registry

MannKind said that Afrezza inhalation powder is a well-tolerated, ultra rapid acting insulin, provide glucose control similar to standard insulin therapy along with weight loss and reduced incidence

Genentech said that the application is based on positive results from a Phase III study, known as ToGA, which showed that people who received Herceptin plus chemotherapy lived

Advanced Cell Technology said that the studies demonstrated an excellent safety profile with no safety signals such as tumors or ectopic tissues. The studies were designed to address

A product development team (PDT) comprised of representatives from Pfizer, MMV and the London School of Hygiene and Tropical Medicine (LSHTM) are expected to coordinate the trials and